Reversible bone marrow dysplasia in patients with systemic lupus erythematosus

Yumiko Oka, Junichi Kameoka, Yasuhiko Hirabayashi, Reiko Takahashi, Tomonori Ishii, Takeshi Sasaki, Hideo Harigae

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Objective: Several reports of bone marrow dysplasia in patients with systemic lupus erythematosus (SLE) have been published. However, the reports are restricted primarily to descriptions of the erythroid lineage; no follow-up studies have been reported, and the clinical significance of the dysplasias is unknown. Therefore, in the present study, the dysplasias noted in bone marrow aspirates obtained from SLE patients were characterized. Patients and Methods: The smears of bone marrow aspirates obtained from 17 SLE patients who had bone marrow aspiration due to cytopenia (WBC<1,500/μl, or Hb<10.5 g/dl, or platelet count <10×104/μl) were examined retrospectively. Of the 17 patients, 4 had a repeat bone marrow aspiration during follow-up. Clinical and laboratory data were obtained from the medical records. Results: Of the 17 SLE patients, 12 had dysplasias, including: erythroid cell multinuclearity (trinuclear or more) (5 patients), megaloblastoid changes (4), pseudo-Pelger abnormalities (6), annular nuclear myeloid cells (2), separated nuclear megakaryocytes (4), and micromegakaryocytes (5). In the 4 patients who had follow-up bone marrow aspiration, these dysplasias were correlated with disease activity; some abnormalities disappeared with remission of SLE. Diffuse proliferative glomerulonephritis (3 patients) and cerebral lupus/neuropsychiatric lupus (4 patients) were seen only in patients with dysplasia. Conclusion: This study found that bone marrow dysplasia can be observed in all lineage cells of SLE patients, and that the dysplasia, is reversible during the course of the disease. The presence of dysplasias appears to be associated with disease severity.

Original languageEnglish
Pages (from-to)737-742
Number of pages6
JournalInternal Medicine
Volume47
Issue number8
DOIs
Publication statusPublished - Jul 11 2008

Fingerprint

Developmental Bone Disease
Systemic Lupus Erythematosus
Bone Marrow
Erythroid Cells
Megakaryocytes
Myeloid Cells
Glomerulonephritis
Platelet Count
Medical Records

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Cite this

Oka, Y., Kameoka, J., Hirabayashi, Y., Takahashi, R., Ishii, T., Sasaki, T., & Harigae, H. (2008). Reversible bone marrow dysplasia in patients with systemic lupus erythematosus. Internal Medicine, 47(8), 737-742. https://doi.org/10.2169/internalmedicine.47.0607

Reversible bone marrow dysplasia in patients with systemic lupus erythematosus. / Oka, Yumiko; Kameoka, Junichi; Hirabayashi, Yasuhiko; Takahashi, Reiko; Ishii, Tomonori; Sasaki, Takeshi; Harigae, Hideo.

In: Internal Medicine, Vol. 47, No. 8, 11.07.2008, p. 737-742.

Research output: Contribution to journalArticle

Oka, Y, Kameoka, J, Hirabayashi, Y, Takahashi, R, Ishii, T, Sasaki, T & Harigae, H 2008, 'Reversible bone marrow dysplasia in patients with systemic lupus erythematosus', Internal Medicine, vol. 47, no. 8, pp. 737-742. https://doi.org/10.2169/internalmedicine.47.0607
Oka Y, Kameoka J, Hirabayashi Y, Takahashi R, Ishii T, Sasaki T et al. Reversible bone marrow dysplasia in patients with systemic lupus erythematosus. Internal Medicine. 2008 Jul 11;47(8):737-742. https://doi.org/10.2169/internalmedicine.47.0607
Oka, Yumiko ; Kameoka, Junichi ; Hirabayashi, Yasuhiko ; Takahashi, Reiko ; Ishii, Tomonori ; Sasaki, Takeshi ; Harigae, Hideo. / Reversible bone marrow dysplasia in patients with systemic lupus erythematosus. In: Internal Medicine. 2008 ; Vol. 47, No. 8. pp. 737-742.
@article{0c244d6a9caa4773a33fe2b0d67aaaa2,
title = "Reversible bone marrow dysplasia in patients with systemic lupus erythematosus",
abstract = "Objective: Several reports of bone marrow dysplasia in patients with systemic lupus erythematosus (SLE) have been published. However, the reports are restricted primarily to descriptions of the erythroid lineage; no follow-up studies have been reported, and the clinical significance of the dysplasias is unknown. Therefore, in the present study, the dysplasias noted in bone marrow aspirates obtained from SLE patients were characterized. Patients and Methods: The smears of bone marrow aspirates obtained from 17 SLE patients who had bone marrow aspiration due to cytopenia (WBC<1,500/μl, or Hb<10.5 g/dl, or platelet count <10×104/μl) were examined retrospectively. Of the 17 patients, 4 had a repeat bone marrow aspiration during follow-up. Clinical and laboratory data were obtained from the medical records. Results: Of the 17 SLE patients, 12 had dysplasias, including: erythroid cell multinuclearity (trinuclear or more) (5 patients), megaloblastoid changes (4), pseudo-Pelger abnormalities (6), annular nuclear myeloid cells (2), separated nuclear megakaryocytes (4), and micromegakaryocytes (5). In the 4 patients who had follow-up bone marrow aspiration, these dysplasias were correlated with disease activity; some abnormalities disappeared with remission of SLE. Diffuse proliferative glomerulonephritis (3 patients) and cerebral lupus/neuropsychiatric lupus (4 patients) were seen only in patients with dysplasia. Conclusion: This study found that bone marrow dysplasia can be observed in all lineage cells of SLE patients, and that the dysplasia, is reversible during the course of the disease. The presence of dysplasias appears to be associated with disease severity.",
author = "Yumiko Oka and Junichi Kameoka and Yasuhiko Hirabayashi and Reiko Takahashi and Tomonori Ishii and Takeshi Sasaki and Hideo Harigae",
year = "2008",
month = "7",
day = "11",
doi = "10.2169/internalmedicine.47.0607",
language = "English",
volume = "47",
pages = "737--742",
journal = "Internal Medicine",
issn = "0918-2918",
publisher = "Japanese Society of Internal Medicine",
number = "8",

}

TY - JOUR

T1 - Reversible bone marrow dysplasia in patients with systemic lupus erythematosus

AU - Oka, Yumiko

AU - Kameoka, Junichi

AU - Hirabayashi, Yasuhiko

AU - Takahashi, Reiko

AU - Ishii, Tomonori

AU - Sasaki, Takeshi

AU - Harigae, Hideo

PY - 2008/7/11

Y1 - 2008/7/11

N2 - Objective: Several reports of bone marrow dysplasia in patients with systemic lupus erythematosus (SLE) have been published. However, the reports are restricted primarily to descriptions of the erythroid lineage; no follow-up studies have been reported, and the clinical significance of the dysplasias is unknown. Therefore, in the present study, the dysplasias noted in bone marrow aspirates obtained from SLE patients were characterized. Patients and Methods: The smears of bone marrow aspirates obtained from 17 SLE patients who had bone marrow aspiration due to cytopenia (WBC<1,500/μl, or Hb<10.5 g/dl, or platelet count <10×104/μl) were examined retrospectively. Of the 17 patients, 4 had a repeat bone marrow aspiration during follow-up. Clinical and laboratory data were obtained from the medical records. Results: Of the 17 SLE patients, 12 had dysplasias, including: erythroid cell multinuclearity (trinuclear or more) (5 patients), megaloblastoid changes (4), pseudo-Pelger abnormalities (6), annular nuclear myeloid cells (2), separated nuclear megakaryocytes (4), and micromegakaryocytes (5). In the 4 patients who had follow-up bone marrow aspiration, these dysplasias were correlated with disease activity; some abnormalities disappeared with remission of SLE. Diffuse proliferative glomerulonephritis (3 patients) and cerebral lupus/neuropsychiatric lupus (4 patients) were seen only in patients with dysplasia. Conclusion: This study found that bone marrow dysplasia can be observed in all lineage cells of SLE patients, and that the dysplasia, is reversible during the course of the disease. The presence of dysplasias appears to be associated with disease severity.

AB - Objective: Several reports of bone marrow dysplasia in patients with systemic lupus erythematosus (SLE) have been published. However, the reports are restricted primarily to descriptions of the erythroid lineage; no follow-up studies have been reported, and the clinical significance of the dysplasias is unknown. Therefore, in the present study, the dysplasias noted in bone marrow aspirates obtained from SLE patients were characterized. Patients and Methods: The smears of bone marrow aspirates obtained from 17 SLE patients who had bone marrow aspiration due to cytopenia (WBC<1,500/μl, or Hb<10.5 g/dl, or platelet count <10×104/μl) were examined retrospectively. Of the 17 patients, 4 had a repeat bone marrow aspiration during follow-up. Clinical and laboratory data were obtained from the medical records. Results: Of the 17 SLE patients, 12 had dysplasias, including: erythroid cell multinuclearity (trinuclear or more) (5 patients), megaloblastoid changes (4), pseudo-Pelger abnormalities (6), annular nuclear myeloid cells (2), separated nuclear megakaryocytes (4), and micromegakaryocytes (5). In the 4 patients who had follow-up bone marrow aspiration, these dysplasias were correlated with disease activity; some abnormalities disappeared with remission of SLE. Diffuse proliferative glomerulonephritis (3 patients) and cerebral lupus/neuropsychiatric lupus (4 patients) were seen only in patients with dysplasia. Conclusion: This study found that bone marrow dysplasia can be observed in all lineage cells of SLE patients, and that the dysplasia, is reversible during the course of the disease. The presence of dysplasias appears to be associated with disease severity.

UR - http://www.scopus.com/inward/record.url?scp=44649135727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44649135727&partnerID=8YFLogxK

U2 - 10.2169/internalmedicine.47.0607

DO - 10.2169/internalmedicine.47.0607

M3 - Article

C2 - 18421190

AN - SCOPUS:44649135727

VL - 47

SP - 737

EP - 742

JO - Internal Medicine

JF - Internal Medicine

SN - 0918-2918

IS - 8

ER -